{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidzfz7gtfxfkfw2laiwpvrf5hzci6jje33hlrc5zk7744izcgn3yi",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mph5cr55thy2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifacnhmcyeetwy3hawtqnnu7qb6vi66ne4iyavxuse5pl2qprguse"
    },
    "mimeType": "image/jpeg",
    "size": 474331
  },
  "path": "/news/2026-06-experimental-drug-alleviates-symptoms-huntington.html",
  "publishedAt": "2026-06-29T14:40:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "The hereditary disorder Huntington's disease has so far been considered incurable. Its clinical manifestations include impaired motor control and psychiatric symptoms. A new study offers promising insights. It shows that a specific drug candidate called anle138b can significantly reduce the toxic protein clumps in the brain that are characteristic of the disease.",
  "title": "Experimental drug alleviates symptoms of Huntington's disease"
}